DolCas Biotech to showcase Curcugen chocolate prototype at Vitafoods Europe 2024
DolCas Biotech has announced that it will be showcasing a new chocolate prototype featuring its Curcugen curcumin ingredient at this year’s Vitafoods Europe.
Image courtesy of DolCas Biotech
DolCas Biotech (Landing, NJ) has announced that it will be showcasing a new chocolate prototype featuring its Curcugen curcumin ingredient at this year’s Vitafoods Europe. This is no easy task, explains DolCas since it requires pairing two astringent ingredients, cocoa and turmeric extract.
“We bring functional chocolate to Switzerland—a country famous for its chocolate—to reinvent the chocolate segment with added better-for-you value,” said Shavon Jackson-Michel, ND, director of medical & scientific affairs for DolCas Biotech, in a press release. “Increased consumer focus on health and wellness continues to drive demand for functional treats. Consumers are seeking convenient ways to incorporate bioactive ingredients into their daily routines, and functional platforms offer a flavorful and accessible option.”
DolCas partnered with a boutique chocolate maker to deliver the ideal chocolate experience. ““The chocolate company successfully addressed the challenges of color and texture and were quite pleased by the mild taste of Curcugen and its ability to readily be applied to the chocolate base,” said K. G. Rao, president of DolCas. “Similarly, we expect customers looking for researched anti-inflammatory and antioxidative actives for other food, beverage, and crossover applications to have an equally great experience with Curcugen.”
Each individually-wrapped 2x2 inch chocolate square will deliver 500 mg of Curcugen. Additionally, the company strengthened its distribution channels and supply chain. “We’ve strengthened our distribution arrangements with IFF which will deepen our foothold in the European market. We have recently opened new offices in Delhi, India and Shanghai, China, strategically positioning ourselves for further expansion and greater efficiency as we pursue our goals for global growth,” explained Rao. “The India and China locations also will serve as sourcing and export houses for DolCas and Orcas ingredient portfolios. The Delhi office will work closely with our raw material production and extraction facilities in Bikanir – where Curcugen is manufactured, to coordinate shipments and distribution globally.”
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.
